Therapeutic Hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin

dc.contributor.authorGencoglan, G
dc.contributor.authorInanir, I
dc.contributor.authorGunduz, K
dc.date.accessioned2025-04-10T10:28:29Z
dc.date.available2025-04-10T10:28:29Z
dc.description.abstractPsychocutaneous conditions are frequently encountered in dermatology practice. Prurigo nodularis and lichen simplex chronicus are two frustrating conditions that are classified in this category. They are often refractory to classical treatment with topical corticosteroids and antihistamines. Severe, generalized exacerbations require systemic therapy. Phototherapy, erythromycine, retinoids, cyclosporine, azathiopurine, naltrexone, and psychopharmacologic agents (pimozide, selective serotonin reuptake inhibitor antidepressants) were tried with some success. Here five cases with lichen simplex chronicus and four cases with prurigo nodularis, who responded well to gabapentin, are presented.
dc.identifier.e-issn1529-8019
dc.identifier.issn1396-0296
dc.identifier.urihttp://hdl.handle.net/20.500.14701/35344
dc.language.isoEnglish
dc.titleTherapeutic Hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin
dc.typeArticle

Files